Logo image of EVAX

EVAXION BIOTECH A/S (EVAX) Stock Price, Quote, News and Overview

NASDAQ:EVAX - Nasdaq - US29970R2040 - ADR - Currency: USD

1.94  -0.16 (-7.62%)

Premarket: 1.9 -0.04 (-2.06%)

EVAX Quote, Performance and Key Statistics

EVAXION BIOTECH A/S

NASDAQ:EVAX (2/28/2025, 8:00:01 PM)

Premarket: 1.9 -0.04 (-2.06%)

1.94

-0.16 (-7.62%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High22.05
52 Week Low1.89
Market Cap12.16M
Shares6.27M
Float6.02M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-25 2025-03-25/amc
IPO02-05 2021-02-05


EVAX short term performance overview.The bars show the price performance of EVAX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

EVAX long term performance overview.The bars show the price performance of EVAX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EVAX is 1.94 USD. In the past month the price decreased by -21.46%. In the past year, price decreased by -88.55%.

EVAXION BIOTECH A/S / EVAX Daily stock chart

EVAX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.66 369.39B
AMGN AMGEN INC 15.54 165.43B
GILD GILEAD SCIENCES INC 24.8 142.43B
VRTX VERTEX PHARMACEUTICALS INC 1654.45 123.26B
REGN REGENERON PHARMACEUTICALS 15.31 76.39B
ARGX ARGENX SE - ADR 242.12 37.96B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.83B
ONC BEIGENE LTD-ADR N/A 29.00B
BNTX BIONTECH SE-ADR N/A 27.07B
NTRA NATERA INC N/A 20.54B
BIIB BIOGEN INC 8.53 20.47B
SMMT SUMMIT THERAPEUTICS INC N/A 15.26B

About EVAX

Company Profile

EVAX logo image Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Company Info

EVAXION BIOTECH A/S

Bredgade 34E, Copenhagen K

COPENHAGEN 1260 DK

CEO: Lars Staal Webner

Employees: 49

Company Website: https://www.evaxion-biotech.com/

EVAXION BIOTECH A/S / EVAX FAQ

What is the stock price of EVAXION BIOTECH A/S today?

The current stock price of EVAX is 1.94 USD. The price decreased by -7.62% in the last trading session.


What is the ticker symbol for EVAXION BIOTECH A/S stock?

The exchange symbol of EVAXION BIOTECH A/S is EVAX and it is listed on the Nasdaq exchange.


On which exchange is EVAX stock listed?

EVAX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for EVAXION BIOTECH A/S stock?

8 analysts have analysed EVAX and the average price target is 47.37 USD. This implies a price increase of 2341.56% is expected in the next year compared to the current price of 1.94. Check the EVAXION BIOTECH A/S stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EVAXION BIOTECH A/S worth?

EVAXION BIOTECH A/S (EVAX) has a market capitalization of 12.16M USD. This makes EVAX a Nano Cap stock.


How many employees does EVAXION BIOTECH A/S have?

EVAXION BIOTECH A/S (EVAX) currently has 49 employees.


What are the support and resistance levels for EVAXION BIOTECH A/S (EVAX) stock?

EVAXION BIOTECH A/S (EVAX) has a resistance level at 2.05. Check the full technical report for a detailed analysis of EVAX support and resistance levels.


Should I buy EVAXION BIOTECH A/S (EVAX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EVAXION BIOTECH A/S (EVAX) stock pay dividends?

EVAX does not pay a dividend.


When does EVAXION BIOTECH A/S (EVAX) report earnings?

EVAXION BIOTECH A/S (EVAX) will report earnings on 2025-03-25, after the market close.


What is the Price/Earnings (PE) ratio of EVAXION BIOTECH A/S (EVAX)?

EVAXION BIOTECH A/S (EVAX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.9).


EVAX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EVAX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EVAX. EVAX may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EVAX Financial Highlights

Over the last trailing twelve months EVAX reported a non-GAAP Earnings per Share(EPS) of -0.9. The EPS increased by 90.53% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -99.83%
ROE -1213.49%
Debt/Equity 7.99
Chartmill High Growth Momentum
EPS Q2Q%90.48%
Sales Q2Q%N/A
EPS 1Y (TTM)90.53%
Revenue 1Y (TTM)N/A

EVAX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to EVAX. The Buy consensus is the average rating of analysts ratings from 8 analysts.


Ownership
Inst Owners2.61%
Ins Owners0.68%
Short Float %N/A
Short Ratio0.04
Analysts
Analysts82.5
Price Target47.37 (2341.75%)
EPS Next Y28.23%
Revenue Next YearN/A